Summary of lymphomas observed in treated mice
Recipient . | Irradiation, Gy . | Transplant . | No. mice . | No. mice with tumor . | Occurrence, wk . | Origin . |
|---|---|---|---|---|---|---|
| Adults | ||||||
| ADA-/- | 6 | GT | 8 | 1 | 16 | Donor |
| ADA-/- | 6 | BMT | 7 | 1 | 27 | Host |
| ADA+/+ | 6 | UT | 9 | 3 | 17-24 | NA |
| ADA+/+ | 0 | UT | 10 | 0 | NA | NA |
| Neonates | ||||||
| ADA-/- | 3 | GT | 12 | 2 | 29-45 | 1 donor, 1 host |
| ADA-/- | 3 | BMT | 22 | 10 | 12-30 | Host |
| ADA+/+ | 3 | UT | 16 | 1 | 24 | NA |
| ADA+/+ | 0 | UT | 17 | 0 | NA | NA |
Recipient . | Irradiation, Gy . | Transplant . | No. mice . | No. mice with tumor . | Occurrence, wk . | Origin . |
|---|---|---|---|---|---|---|
| Adults | ||||||
| ADA-/- | 6 | GT | 8 | 1 | 16 | Donor |
| ADA-/- | 6 | BMT | 7 | 1 | 27 | Host |
| ADA+/+ | 6 | UT | 9 | 3 | 17-24 | NA |
| ADA+/+ | 0 | UT | 10 | 0 | NA | NA |
| Neonates | ||||||
| ADA-/- | 3 | GT | 12 | 2 | 29-45 | 1 donor, 1 host |
| ADA-/- | 3 | BMT | 22 | 10 | 12-30 | Host |
| ADA+/+ | 3 | UT | 16 | 1 | 24 | NA |
| ADA+/+ | 0 | UT | 17 | 0 | NA | NA |
The time in which the lymphoma developed is shown as the range.
UT indicates no treatment; NA, not applicable.